Olive Branch Health Files Prospectus to Expand Cross-Border Consumer Healthcare Platform

With the continuous improvement of living standards among Chinese residents, the number of individuals seeking cross-border medical services has been increasing year by year. Chinese patients are becoming frequent visitors to top-tier medical institutions worldwide. According to the "White Paper on Cross-Border Medical and Health Services for China’s High-Net-Worth Individuals," the market size for cross-border healthcare was projected to reach RMB 58.1 billion in 2020, with an expected annual growth rate of up to 50% in the coming years.

The demand among Chinese patients for overseas medical care encompasses critical care treatment, as well as services such as medical aesthetics, health check-ups, and vaccinations. A survey indicated that in 2016, critical care treatment accounted for 40.8% of cross-border medical services, while health check-ups, medical aesthetics, and assisted reproductive technology comprised 24.6%, 12.8%, and 10%, respectively.

Deng Guiwei, founder of GLZHealth, believes that as China’s economic level rises, more users are seeking a healthy lifestyle rather than just cross-border medical treatment. Demand for cross-border consumer healthcare services—such as maternity care, health check-ups, medical aesthetics, and vaccinations—will continue to grow.

GLZHealth is committed to providing users with cross-border online medical product consultation and appointment services, carefully selecting high-quality global medical institutions and products, with a focus on vaccines, maternity care, health checkups, medical aesthetics, dentistry, and wellness.

It is reported that within two years, GLZHealth’s health consultation service reached 1.82 million users, with its cooperative network covering Hong Kong, Macao, Taiwan, Singapore, South Korea, Japan, Malaysia, Thailand, the United States, and the United Kingdom. The company has established partnerships with over 400 medical institutions and facilitated connections with more than 1,000 medical facilities in total, while collaborating with platform organizations such as Ali Health.Now grown into one of China’s largest cross-border consumer healthcare service platforms.。

Deng Guiwei stated that public medical institutions remain the primary providers of basic medical services in China, where informatization requirements are focused more on assisting and enhancing medical efficiency. In contrast, non-public medical institutions need to engage in more market-oriented activities, integrating digitalization into earlier stages such as brand building and customer acquisition—for example, by establishing comprehensive digital marketing systems through strategic informatization initiatives.

Therefore, Deng Guiwei believes: “Compared to public institutions, which boast a large user base and concentrated medical scenarios,Non-public institutions are fragmented and numerous, making them even more in need of digital marketing systems to support their growth, particularly in the consumer healthcare sector.”

Currently, China’s healthcare market remains dominated by public hospitals. Although policies are advocating for the development of private healthcare and the separation of prescribing from dispensing, the scale of private medical institutions is still in the process of expansion. In contrast, overseas, most primary care services are provided primarily by non-public medical institutions, particularly in the consumer healthcare sector.

In addition, during field research, the GLZHealth team found that overseas private medical institutions focus more on offline services, generally suffering from low efficiency and fragmented user reputation, while lacking corresponding digital marketing systems.

Deng Guiwei stated, “With consumption upgrades and an increasingly aging population, China has become the world’s largest single health consumer market. Customer demand for cross-border healthcare is gradually extending into areas such as medical aesthetics, assisted reproduction, and health check-ups.” In 2017, he led his team in founding GLZHealth, deciding to enter the cross-border consumer healthcare market through an internet platform model. This approach not only helps C-end users better access information on the cross-border consumer healthcare market but also enhances the service efficiency of medical institutions, thereby building brand influence.

By establishing an internet platform that connects the supply and demand sides of cross-border consumer healthcare, users can independently select institutions and services on the platform. Meanwhile, overseas institutions can also enhance their visibility and build their brands in the Chinese market through online channels. Some medical brands with high recognition abroad can leverage this platform model to establish their brand presence in the Chinese market for the first time.

Based on the current state of China’s healthcare market and user demands, GLZHealth initially centered its strategy around vaccines to enter the cross-border consumer healthcare market.

Deng Guiwei stated, “The vaccine market is the simplest, with the lowest barriers to entry and the largest user base, but it also faces intense competitive pressure. When GLZHealth was established, the cross-border vaccine market was chaotic and largely dominated by offline intermediaries. This led to opaque market information, mutual price markups among intermediaries, inconsistent quality of service providers, and unclear vaccine sources, among other issues. As a result, consumer interests were not adequately protected, and any incidents would erode users’ confidence in overseas markets.”

To address the various issues existing in the cross-border vaccine market, GLZHealth has establishedOne-Stop Internet Service Platform, liaise with high-quality overseas medical institutions, establish supply chain selection criteria, trace the vaccine sources of these institutions, and conduct on-site visits. Furthermore, by integrating institutions through an appointment system, the booking speed has been significantly improved.

Meanwhile, GLZHealth alsoFirst timeEstablished an Evaluation System for Overseas Medical Institution ServicesBy leveraging authentic reviews from in-person customers, the platform enables users to make more confident and hassle-free decisions when selecting healthcare institutions and services. By bridging geographical, cultural, and language gaps, it helps users establish access to care while assisting institutions in standardizing their service systems and building their brands.

Furthermore, traditional cross-border medical institutions are unable to guarantee after-sales support. The platforms under GLZHealth have established relevant regulations and constraints to address users’ refund and after-sales service issues.

It is understood that GLZHealth currently enables users to schedule vaccinations at medical institutions in more than 10 countries and regions, including Singapore, Hong Kong, Macau, Malaysia, and South Korea. Available vaccines include pediatric vaccines (such as hepatitis A/B vaccines, pentavalent/hexavalent combination vaccines, and oral rotavirus vaccines) and adult vaccines (such as HPV vaccines, 13-valent pneumococcal conjugate vaccines, influenza vaccines, and shingles vaccines).

Deng Guiwei stated, “In just over a year since its establishment, GLZHealth has become one of the leaders in the cross-border vaccination market. Subsequently, the company began to replicate its successful experience in the vaccine industry and explore the fields of health check-ups, assisted reproduction, and medical aesthetics.”

Currently, the company provides customers with full-lifecycle services, encompassing a comprehensive range of offerings including health check-ups, specialized diagnosis and treatment, assisted reproductive technology (ART), non-invasive prenatal testing (NIPT), genetic testing, pediatric vaccinations, adult vaccinations, and medical aesthetics.

Deng Guiwei stated, “Previously, a well-known overseas medical institution had only a few Chinese users per month. After partnering with GLZHealth, its monthly domestic customer base surged to over 1,000, achieving explosive growth.” By carefully curating medical services, the company has extended its more localized offline brand services to a broader market of users through digitalization.

Digitalization extends beyond online channels. When users arrive at a healthcare facility, language barriers may hinder on-site service purchases. In such cases, users can directly purchase services through the GLZHealth online platform and resolve after-sales issues via online customer service coordination.

According to company records, GLZHealth was established in 2017, focusing on Hong Kong, Macao, and Taiwan as its core markets while also entering South Korea and Southeast Asia.

In 2018, the company partnered with Alibaba Health to launch online medical services under the Hong Kong Pavilion, andRanked in the Top 5 of the Double 11 Overall Medical Services List, with single-day revenue exceeding RMB 16.5 millionAs of 2018, the company had partnered with over 200 medical institutions and served more than 1.82 million users annually, securing a leading position in the cross-border consumer healthcare services market.

In 2019, GLZHealth partnered with Ping An Health Insurance to launch a campaign for the “38 Goddess Festival,” achieving nearly 5 million cumulative impressions. It also signed cooperation agreements with domestic healthcare platforms such as WeDoctor to launch overseas premium medical service programs. To date, GLZHealth has collaborated with over 400 medical institutions and serves 1.82 million members annually, building a substantial client base and strong reputation.

Deng Guiwei stated, “Unlike other industries, the most critical factor in cross-border consumer healthcare is word-of-mouth reputation.” Currently, GLZHealth has accumulated over 100,000 positive reviews across its online platforms. This strong reputation has become one of GLZHealth’s core competitive advantages, driving its continuous growth and development.

Going forward, GLZHealth will continue to deepen its presence in the cross-border consumer healthcare market by strengthening collaborations with medical institutions in Japan, South Korea, Singapore, Malaysia, and the Hong Kong, Macao, and Taiwan regions. “Additionally, the company will remain committed to leveraging internet-based approaches to enhance industry efficiency and transparency, enabling customers to access more information on cross-border medical care, find their preferred hospitals more conveniently, and obtain services more quickly and seamlessly.”

Deng Guiwei mentioned that GLZHealth will serve clients in more countries and regions at the appropriate time. Globally, due to the complex interplay of factors such as geography, scientific research, and policies, there are significant disparities in medical services across different countries and regions, each with its own areas of expertise, such as Japan’s precision health checkups and South Korea’s medical aesthetics.

Deng Guiwei observed, “Patients from the Middle East and Russia travel to South Korea for medical treatment, while those from Hong Kong and Macau go to Japan, and Indonesians seek care in Malaysia and Singapore.” Focusing on facilitating the flow of medical resources across multiple regions may represent one development path for cross-border healthcare institutions.